Tuesday, August 31, 2010

New Report Clinical Trials Market in Brazil, Russia, India, India (BRIC) (2010 - 2015) Published By MarketsandMarkets

Clinical trials market is evidencing a significant growth in emerging economies. India, especially is illustrating significant growth rate due to its large patient base with diverse gene pool that allows the Pharma companies and CROs to conduct clinical trials in more effective method. The average cost savings in conducting clinical trials in BRIC economies extends from 20% to 60%. However, increased interaction and review of ethical committees and training would provide cohesive environment that can further boost the market for clinical trials in developing economies.
Browse in-depth ToC on Clinical Trials Market in Brazil, Russia, India, India (BRIC) (2010 – 2015)
Early buyers will receive 10% customization of reports 
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the globe. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M Banking and Financial Services Practice recognize the challenges that financial institutions face while bringing the right products to market. Our reports and consulting practice provides a unique perspective allowing financial institutions to understand and strategize to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how our clients can create, capture, and retain the value of their products and outthink the competition.
Ms. Sunita
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

No comments: